0001127602-12-033818.txt : 20121213 0001127602-12-033818.hdr.sgml : 20121213 20121213153024 ACCESSION NUMBER: 0001127602-12-033818 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121211 FILED AS OF DATE: 20121213 DATE AS OF CHANGE: 20121213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EBERLY RICHARD CENTRAL INDEX KEY: 0001224658 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 121262043 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-12-11 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001224658 EBERLY RICHARD 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 EVP,Pres Meridian Life Science Common Stock 2012-12-11 4 M 0 5250 0 A 42996 D Common Stock 2012-12-11 4 M 0 10500 0 A 53496 D Common Stock 2012-12-11 4 M 0 15750 0 A 69246 D Common Stock 2012-12-11 4 S 0 31500 20.4654 D 37746 D Stock Options (Right to Buy) 7.28 2012-12-11 4 M 0 5250 0 D 2014-12-07 Common Stock 5250 0 D Stock Options (Right to Buy) 14.007 2012-12-11 4 M 0 10500 0 D 2015-11-10 Common Stock 10500 0 D Stock Options (Right to Buy) 16.554 2012-12-11 4 M 0 15750 0 D 2016-11-15 Common Stock 15750 0 D Prices range from $20.3766 per share to $20.5609 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer. These options became fully vested in November 2008. These options became fully vested in November 2009. These options became fully vested in November 2010. /s/ Melissa A. Lueke as Attorney-in-Fact for Richard Eberly 2012-12-13